<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00523783</url>
  </required_header>
  <id_info>
    <org_study_id>NIS-NKR-SER-2007/1</org_study_id>
    <nct_id>NCT00523783</nct_id>
  </id_info>
  <brief_title>Seroquel Long-Term NIS for Schizophrenia Patients</brief_title>
  <acronym>SELECT</acronym>
  <official_title>24-Week Naturalistic Observational Study of Efficacy of Quetiapine in Patients With Schizophrenia or Schizoaffective Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the efficacy of 24-week treatment with quetiapine in patients with schizophrenia or
      schizoaffective disorder
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">November 2007</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Schizoaffective Disorder</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient and the patient's legal representative (if any) must understand the nature
             of the study and must have given written consent

          -  The patient suffers from schizophrenia or schizoaffective disorder according to
             DSM-IV-TR

          -  The patient is between 18 and 65 years old(extremes included)

          -  On the basis of physical and neurological examination, medical history, the patient
             is, in the investigator's opinion, otherwise healthy

          -  If the subject is a female of childbearing potential, she must be not pregnant or
             breast-feeding and be using a reliable method of contraception. Reliable methods may
             include abstinence, hormonal contraceptives (eg,oral contraceptives or long-term
             injectable or implantable hormonal contraceptives), double-barrier methods (eg, condom
             and diaphragm, condom and foam, condom and sponge), intrauterine devices, and tubal
             ligation

        Exclusion Criteria:

          -  The patients who have known hypersensitivity to quetiapine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joon-Woo Bahn</last_name>
    <role>Study Director</role>
    <affiliation>AstraZeneca Korea</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Seoul</city>
        <state>Dongdamoon-gu</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Seoul</city>
        <state>Kangnam-gu</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Seoul</city>
        <state>Songpa-gu</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <removed_countries>
    <country>Korea, Democratic People's Republic of</country>
  </removed_countries>
  <link>
    <url>http://www.astrazeneca.com/node/emailtriage.aspx</url>
  </link>
  <verification_date>August 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 29, 2007</study_first_submitted>
  <study_first_submitted_qc>August 30, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2007</study_first_posted>
  <last_update_submitted>October 3, 2008</last_update_submitted>
  <last_update_submitted_qc>October 3, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 6, 2008</last_update_posted>
  <keyword>Schizophrenia</keyword>
  <keyword>Schizoaffective</keyword>
  <keyword>quetiapine</keyword>
  <keyword>long-term efficacy</keyword>
  <keyword>Naturalistic</keyword>
  <keyword>Observational</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Quetiapine Fumarate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

